| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Creutzfeldt-Jakob disease: reflections on the risk from blood product therapy
|
BROWN, P.
|
|
2007
|
13 |
s5 |
p. 33-40
|
artikel
|
| 2 |
Diagnosis and treatment of von Willebrand disease: new perspectives and nuances
|
KESSLER, C. M.
|
|
2007
|
13 |
s5 |
p. 3-14
|
artikel
|
| 3 |
Factor VIII inhibitors: role of von Willebrand factor on the uptake of factor VIII by dendritic cells
|
KAVERI, S. V.
|
|
2007
|
13 |
s5 |
p. 61-64
|
artikel
|
| 4 |
Factor VIII products and inhibitor development: the SIPPET study (survey of inhibitors in plasma-product exposed toddlers)
|
MANNUCCI, P. M.
|
|
2007
|
13 |
s5 |
p. 65-68
|
artikel
|
| 5 |
Fanhdi®, efficacy and safety in von Willebrand’s disease: prospective international study results
|
BELLO, I. F.
|
|
2007
|
13 |
s5 |
p. 25-32
|
artikel
|
| 6 |
Highly purified VWF/FVIII concentrates in the treatment and prophylaxis of von Willebrand disease: the PRO.WILL Study
|
FEDERICI, A. B.
|
|
2007
|
13 |
s5 |
p. 15-24
|
artikel
|
| 7 |
History of haemophilia
|
ALEDORT, L. M.
|
|
2007
|
13 |
s5 |
p. 1-2
|
artikel
|
| 8 |
Inhibitor development in haemophilia A: the role of von Willebrand factor/factor VIII concentrates
|
GOUDEMAND, J.
|
|
2007
|
13 |
s5 |
p. 47-51
|
artikel
|
| 9 |
Inhibitors in haemophilia A: current management and open issues
|
HAYA, S.
|
|
2007
|
13 |
s5 |
p. 52-60
|
artikel
|
| 10 |
Safety procedures of coagulation factors
|
JORQUERA, J. I.
|
|
2007
|
13 |
s5 |
p. 41-46
|
artikel
|
| 11 |
VWF/FVIII complex and the management of patient with inhibitors: from laboratory to clinical practice
|
BERNTORP, E.
|
|
2007
|
13 |
s5 |
p. 69-72
|
artikel
|
| 12 |
VWF/FVIII concentrates in high-risk immunotolerance: the RESIST study
|
GRINGERI, A.
|
|
2007
|
13 |
s5 |
p. 73-77
|
artikel
|
Tijdschrift beschrijving